semaglutide com Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes SkinnyRx | Compounded Sublingual Semaglutide
Description
Persistence remains mixed: a 2024 real-world study found 32% on therapy at 1 year among non-diabetic users, and according to Prime Therapeutics, only 1 in 12 remain at 3 years
Around 3.1 to 3.8% of patients discontinued the treatment due to gastrointestinal side effects
Alcohol Avoiding alcohol is also advisable
Data Availability No data were analysed in the study
If pregnancy is recognized during treatment, the medication should be discontinued immediately and the healthcare provider contacted promptly
